Palacios Wealth Management LLC Acquires Shares of 41,624 Clover Health Investments, Corp. (NASDAQ:CLOV)

Palacios Wealth Management LLC acquired a new stake in Clover Health Investments, Corp. (NASDAQ:CLOV) in the 4th quarter, according to the company in its most recent filing with the SEC. The fund acquired 41,624 shares of the company’s stock, valued at approximately $131,000.

Other institutional investors have also recently bought and sold shares of the company. Forum Financial Management LP lifted its stake in shares of Clover Health Investments by 33.8% during the third quarter. Forum Financial Management LP now owns 16,077 shares of the company’s stock valued at $45,000 after acquiring an additional 4,061 shares during the period. Steph & Co. lifted its stake in shares of Clover Health Investments by 33.3% during the fourth quarter. Steph & Co. now owns 20,000 shares of the company’s stock valued at $63,000 after acquiring an additional 5,000 shares during the period. SignalPoint Asset Management LLC lifted its stake in shares of Clover Health Investments by 6.2% during the fourth quarter. SignalPoint Asset Management LLC now owns 160,074 shares of the company’s stock valued at $504,000 after acquiring an additional 9,390 shares during the period. Bleakley Financial Group LLC lifted its stake in shares of Clover Health Investments by 98.9% during the third quarter. Bleakley Financial Group LLC now owns 20,090 shares of the company’s stock valued at $57,000 after acquiring an additional 9,988 shares during the period. Finally, Concurrent Investment Advisors LLC acquired a new position in shares of Clover Health Investments during the third quarter valued at $28,000. Institutional investors own 19.77% of the company’s stock.

Clover Health Investments Stock Up 1.6 %

Shares of CLOV opened at $4.54 on Friday. Clover Health Investments, Corp. has a 12-month low of $0.61 and a 12-month high of $4.87. The stock’s fifty day simple moving average is $3.76 and its 200-day simple moving average is $3.38. The firm has a market capitalization of $2.28 billion, a PE ratio of -22.70 and a beta of 1.99.

Analyst Ratings Changes

Separately, Craig Hallum started coverage on Clover Health Investments in a research note on Tuesday, December 17th. They set a “buy” rating and a $6.00 price target on the stock.

Clover Health Investments Company Profile

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.